| 2019-06-18 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 2,100 | $87.82 | $184,416.54 | -1.5% | → |
| 2019-06-13 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 17,268 | $82.62 | $1,426,627.81 | -5.7% | → |
| 2019-06-03 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 3,435 | $85.51 | $293,718.61 | -2.4% | → |
| 2019-05-31 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 19,297 | $85.02 | $1,640,580.77 | -12.0% | → |
| 2019-05-24 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 17,486 | $80.03 | $1,399,434.31 | -11.0% | → |
| 2019-05-22 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 1,300 | $80.03 | $104,037.05 | -0.9% | → |
| 2019-05-16 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 66,667 | $80.13 | $5,341,893.38 | -10.5% | → |
| 2019-05-13 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 1,657 | $75.44 | $125,007.23 | -1.4% | → |
| 2019-05-13 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 34,547 | $75.51 | $2,608,813.25 | -19.6% | → |
| 2019-03-12 | NEUROCRINE BIOSCIENCES INC | 10% Owner | Buy | 4,179,728 | $11.96 | $49,999,996.20 | New | → |
| 2019-02-06 | Gano Kyle | Chief Business Development Off | Sell | 762 | $83.56 | $63,672.64 | -0.9% | → |
| 2019-02-06 | Lloyd-Smith Malcolm | Chief Regulatory Officer | Sell | 920 | $83.58 | $76,893.78 | -4.6% | → |
| 2019-02-06 | Lippoldt Darin | Chief Legal Officer | Sell | 791 | $83.52 | $66,063.37 | -3.9% | → |
| 2019-02-06 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 531 | $84.03 | $44,621.58 | -0.4% | → |
| 2019-02-06 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 4,096 | $84.23 | $344,985.60 | -1.0% | → |
| 2019-02-06 | Bozigian Haig P. | Chief Development Officer | Sell | 920 | $83.54 | $76,859.38 | -0.6% | → |
| 2019-02-06 | BENEVICH ERIC | Chief Commercial Officer | Sell | 920 | $83.57 | $76,883.02 | -4.2% | → |
| 2019-02-05 | Lloyd-Smith Malcolm | Chief Regulatory Officer | Sell | 1,272 | $88.14 | $112,118.58 | -3.6% | → |
| 2019-02-05 | Lippoldt Darin | Chief Legal Officer | Sell | 1,225 | $88.09 | $107,910.57 | -3.3% | → |
| 2019-02-05 | BENEVICH ERIC | Chief Commercial Officer | Sell | 1,357 | $88.01 | $119,426.71 | -3.6% | → |
| 2019-02-05 | GORMAN KEVIN CHARLES | Chief Executive Officer | Sell | 7,614 | $88.16 | $671,216.18 | -0.6% | → |
| 2019-02-05 | Gano Kyle | Chief Business Development Off | Sell | 3,809 | $88.12 | $335,667.92 | -1.1% | → |
| 2019-02-05 | Bozigian Haig P. | Chief Development Officer | Sell | 2,725 | $88.12 | $240,125.44 | -0.7% | → |
| 2019-02-05 | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 2,445 | $88.14 | $215,504.88 | -0.7% | → |
| 2019-01-08 | ROBERTS EIRY | Chief Medical Officer | Sell | 1,857 | $84.09 | $156,158.66 | -37.1% | → |
| 2018-12-03 | ABERNETHY MATT | Chief Financial Officer | Sell | 1,178 | $90.00 | $106,019.65 | -37.7% | → |
| 2018-11-26 | POPS RICHARD F | Director | Sell | 4,124 | $91.37 | $376,789.67 | -12.3% | → |
| 2018-11-12 | POPS RICHARD F | Director | Sell | 4,123 | $103.30 | $425,892.71 | -10.9% | → |
| 2018-11-08 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 36,295 | $110.00 | $3,992,450.00 | -11.8% | → |
| 2018-11-07 | Bozigian Haig P. | Chief Development Officer | Sale+OE | 29,399 | $110.14 | $3,238,132.34 | -6.7% | → |
| 2018-11-07 | Lloyd-Smith Malcolm | Chief Regulatory Officer | Sale+OE | 3,300 | $110.00 | $363,000.00 | -17.7% | → |